{2-bromo-6-methoxy-4-[(1-(4-methoxyphenyl)-2,4,6-trioxotetrahydro-5(2H)-pyrimidinylidene)methyl]phenoxy}acetic acid

{2-bromo-6-methoxy-4-[(1-(4-methoxyphenyl)-2,4,6-trioxotetrahydro-5(2H)-pyrimidinylidene)methyl]phenoxy}acetic acid Struktur
347394-43-8
CAS-Nr.
347394-43-8
Englisch Name:
{2-bromo-6-methoxy-4-[(1-(4-methoxyphenyl)-2,4,6-trioxotetrahydro-5(2H)-pyrimidinylidene)methyl]phenoxy}acetic acid
Synonyma:
{2-bromo-6-methoxy-4-[(1-(4-methoxyphenyl)-2,4,6-trioxotetrahydro-5(2H)-pyrimidinylidene)methyl]phenoxy}acetic acid;Acetic acid, 2-[2-bromo-6-methoxy-4-[[tetrahydro-1-(4-methoxyphenyl)-2,4,6-trioxo-5(2H)-pyrimidinylidene]methyl]phenoxy]-
CBNumber:
CB32027440
Summenformel:
C21H17BrN2O8
Molgewicht:
505.27
MOL-Datei:
347394-43-8.mol

{2-bromo-6-methoxy-4-[(1-(4-methoxyphenyl)-2,4,6-trioxotetrahydro-5(2H)-pyrimidinylidene)methyl]phenoxy}acetic acid Eigenschaften

Dichte
1.607±0.06 g/cm3(Predicted)
pka
3.00±0.10(Predicted)

Sicherheit

{2-bromo-6-methoxy-4-[(1-(4-methoxyphenyl)-2,4,6-trioxotetrahydro-5(2H)-pyrimidinylidene)methyl]phenoxy}acetic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

{2-bromo-6-methoxy-4-[(1-(4-methoxyphenyl)-2,4,6-trioxotetrahydro-5(2H)-pyrimidinylidene)methyl]phenoxy}acetic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


{2-bromo-6-methoxy-4-[(1-(4-methoxyphenyl)-2,4,6-trioxotetrahydro-5(2H)-pyrimidinylidene)methyl]phenoxy}acetic acid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Interbioscreen Ltd. --
screen@ibscreen.chg.ru Finland 6178 60
PHARMEKS Ltd. --
sales@pharmeks.com Finland 6350 50
Specs --
info@specs.net The Netherlands 6835 70

  • {2-bromo-6-methoxy-4-[(1-(4-methoxyphenyl)-2,4,6-trioxotetrahydro-5(2H)-pyrimidinylidene)methyl]phenoxy}acetic acid
  • Acetic acid, 2-[2-bromo-6-methoxy-4-[[tetrahydro-1-(4-methoxyphenyl)-2,4,6-trioxo-5(2H)-pyrimidinylidene]methyl]phenoxy]-
  • 347394-43-8
  • C21H17BrN2O8
Copyright 2019 © ChemicalBook. All rights reserved